VENOUS THROMBOEMBOLISM PROPHYLAXIS IN MEDICAL INPATIENTS AND ADHERENCE TO GUIDELINE RECOMMENDATIONS: A PROSPECTIVE STUDY

被引:0
作者
Kalantari, Elham [1 ]
Mousavi, Sarah [2 ]
Samani, Atieh Aliyar [2 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Fac Pharm & Pharmaceut Sci, Dept Internal Med, Esfahan, Iran
[2] Isfahan Univ Med Sci, Sch Med, Fac Pharm & Pharmaceut Sci, Dept Clin Pharm & Pharm Practice, Hezar Jerib Ave, Esfahan, Iran
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2016年 / 7卷 / 09期
关键词
Venous Thromboembolism; Guideline Adherence; Medical Inpatients;
D O I
10.13040/IJPSR.0975-8232.7(9).3787-93
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Venous thromboembolism (VTE) is a common complication during and after hospitalization for medical patients. Previous studies have shown that only about one third of high risk medical patients receives VTE prophylaxis. Guidelines such as the one produced by the American college of Chest Physicians (ACCP) are aimed at reducing hospital associated VTE. The objective of this study was to determine the appropriateness of VTE prophylaxis in medical inpatients at a large teaching hospital. Methods: In a prospective cross-sectional study, VTE prophylaxis were evaluated and the data were recorded during October 2014 to March 2015 in medical wards of "Alzahra" hospital, Isfahan, Iran. A caprini score, a VTE risk factor assessment tool was calculated for each patient based on data collected. Appropriate prophylaxis was determined after examining data, caprini score and prophylaxis regimen according to the ACCP 9th edition guideline. Results: A total of 100 patients met the inclusion criteria and were reviewed. According to the risk stratification, 18 patients classified as low risk, 30 as moderate and 47 as high risk. 66% of patients did not receive appropriate prophylaxis in accordance with the guideline. Adherence to VTE prophylaxis for high-risk patients was 100% for pharmacological prophylaxis and 5% for mechanical prophylaxis. Conclusion: VTE prophylaxis was underutilized in high-risk medical inpatients in our center, on the other hand it is overused in low-risk patients. There is a need to implement a program to improve VTE awareness and prophylaxis. Also the hospital should develop a formal strategy, including a local guideline for VTE prevention.
引用
收藏
页码:3787 / 3793
页数:7
相关论文
共 50 条
[21]   Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis [J].
Sjaelander, A. ;
Jansson, J. -H. ;
Bergqvist, D. ;
Eriksson, H. ;
Carlberg, B. ;
Svensson, P. .
JOURNAL OF INTERNAL MEDICINE, 2008, 263 (01) :52-60
[22]   Venous thromboembolism prophylaxis in medical patients: Future perspectives [J].
Imberti, D ;
Prisco, D .
THROMBOSIS RESEARCH, 2005, 116 (05) :365-375
[23]   Venous Thromboembolism Prophylaxis in the Medical Patient: Controversies and Perspectives [J].
Spyropoulos, Alex C. ;
Mahan, Charles .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (12) :1077-1084
[24]   Quality gap in venous thromboembolism prophylaxis practices in inpatients: Assessment of prophylaxis practices in a University Hospital [J].
Guven, Alper Tuna ;
Altintop, Sabri Engin ;
Ozdede, Murat ;
Uyaroglu, Oguz Abdullah ;
Tanriover, Mine Durusu .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2021, 33 (03)
[25]   The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran [J].
Mohammadreza Amirsadri ;
Sarah Mousavi ;
Ali Karimipour .
DARU Journal of Pharmaceutical Sciences, 2019, 27 :627-634
[26]   The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran [J].
Amirsadri, Mohammadreza ;
Mousavi, Sarah ;
Karimipour, Ali .
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 27 (02) :627-634
[27]   Prophylaxis against venous thromboembolism in acutely ill medical patients: An observational study [J].
Peterman, Carla M. ;
Kolansky, Daniel M. ;
Spinler, Sarah A. .
PHARMACOTHERAPY, 2006, 26 (08) :1086-1090
[28]   Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey [J].
Petra Jancar ;
Tina Morgan ;
Ales Mrhar ;
Mitja Kosnik ;
Mitja Lainscak .
Wiener klinische Wochenschrift, 2009, 121 :318-323
[29]   United Kingdom recommendations for obstetric venous thromboembolism prophylaxis: Evidence and rationale [J].
Lamont, M. Christy ;
McDermott, Christopher ;
Thomson, Andrew J. ;
Greer, Ian A. .
SEMINARS IN PERINATOLOGY, 2019, 43 (04) :222-228
[30]   Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey [J].
Jancar, Petra ;
Morgan, Tina ;
Mrhar, Ales ;
Kosnik, Mitja ;
Lainscak, Mitja .
WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (9-10) :318-323